These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 25682970)
41. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months. De Almeida EA; Prata MM Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839 [TBL] [Abstract][Full Text] [Related]
46. Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study. Serra AL; Kistler AD; Poster D; Struker M; Wüthrich RP; Weishaupt D; Tschirch F BMC Nephrol; 2007 Sep; 8():13. PubMed ID: 17868472 [TBL] [Abstract][Full Text] [Related]
47. An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease. Santoro D; Pellicanò V; Visconti L; Trifirò G; Buemi M; Cernaro V Expert Opin Investig Drugs; 2015; 24(9):1199-218. PubMed ID: 26125126 [TBL] [Abstract][Full Text] [Related]
48. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease. Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132 [TBL] [Abstract][Full Text] [Related]
49. Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease. Haseebuddin M; Tanagho YS; Millar M; Roytman T; Chen C; Clayman RV; Miller B; Desai A; Benway B; Bhayani S; Figenshau RS J Urol; 2012 Oct; 188(4):1239-44. PubMed ID: 22902029 [TBL] [Abstract][Full Text] [Related]